Robert E. Sell, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 3,750 shares at $152.92 ($573K) on 2017-12-26, disclosed to the SEC on 2017-12-27.
Seasonal sale ($573k) by Group Chief Exec-Com, Med & Technology — this insider has traded ACN in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ACN | SELL | 2017-10-03 | $469K | — | Filing → |
| ACN | SELL | 2017-06-27 | $369K | — | Filing → |
| ACN | SELL | 2017-04-28 | $329K | — | Filing → |